Oxervate
Ended Awarded Last action
- Contract number
- 36C26021F0273
- Awardee
-
Dompe U.s. Inc. UEI ECCDSKQAN2J3
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $70,914
Award facts
- Opportunity
-
- 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refresh - October 2010 - Version R4 Solicitation · Posted Feb 21, 2014
- Contract value 100% obligated
- $70,914.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $70,914 |
About this award
Dompe U.S. Inc. was awarded a $70,914.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the drug OXERVATE to be delivered to Boston, MA by August 31, 2021. The delivery order was issued off GSA Schedule 61-IB and has no set aside designation. The VHA will utilize OXERVATE through this contract to support healthcare services for veterans in the New England region.
Quick answers
Who was awarded contract 36C26021F0273?
36C26021F0273 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 10, 2021.
How much is contract 36C26021F0273 worth?
The government has obligated $70,914 on 36C26021F0273.
Is contract 36C26021F0273 an order under another contract?
Yes. 36C26021F0273 is a delivery order under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26021F0273 competed?
The extent of competition for 36C26021F0273 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award